MET and cancer: HGF reactivates MET, EGFR and RON phosphorylation and restores AKT, ERK and WNK1 signaling upon MET inhibition (Figure 3, Figure 5, Supplementary Figure 5), promoting the survival of MET-inhibited cancer cells.